All In MedTech

FDA Clearance Tracker · K192207

Trevo NXT ProVue Retriever

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Nov 22, 2019 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Nov 22, 2019

Substantially Equivalent

Time to decision

100 days

Received Aug 14, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K192207
Device name
Trevo NXT ProVue Retriever
Applicant
Stryker
Applicant location
Fremont, CA
Received
Aug 14, 2019
Decided
Nov 22, 2019
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 882.5600

Every decision under product code POL

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code POL. The earliest in FDA's data is DEN150049, decided Sep 2, 2016.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Stryker

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.